Literature DB >> 22496225

Herpes simplex virus glycoproteins gH/gL and gB bind Toll-like receptor 2, and soluble gH/gL is sufficient to activate NF-κB.

Valerio Leoni1, Tatiana Gianni, Stefano Salvioli, Gabriella Campadelli-Fiume.   

Abstract

A number of sentinels sense incoming herpes simplex virus (HSV) virions and initiate an immediate innate response. The first line of defense at the cell surface is TLR2 (Toll-like receptor 2), whose signature signaling activity leads to activation of the key transcription factor NF-κB. We report that the HSV pathogen-associated molecular patterns for TLR2 are the virion glycoproteins gH/gL and gB, which constitute the conserved fusion core apparatus across the members of the Herpesviridae family. Specifically, virions devoid singly of one of essential fusion glycoproteins (gD, gB, or gH null), able to attach to cells but defective in fusion/entry, were sufficient to elicit the first wave of NF-κB response to HSV. The most effective were the gD-null virions, positive for gH/gL and gB. A soluble form of gB, truncated upstream of the transmembrane sequence (gB(730t-st)), was produced in human cells and purified by means of a Strep tag. gH/gL and gB were each able to physically interact with TLR2 in coimmunoprecipitation assays, one independently of the other, yet gH(t-st)/gL, but not gB(730t-st), elicited an NF-κB response. Thus, whereas both HSV gH/gL and gB are ligands to TLR2, only gH/gL is sufficient to initiate a signaling cascade which leads to NF-κB activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496225      PMCID: PMC3393584          DOI: 10.1128/JVI.00295-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

Review 1.  Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry.

Authors:  D Shukla; P G Spear
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases.

Authors:  M D'Addario; A Ahmad; A Morgan; J Menezes
Journal:  J Mol Biol       Date:  2000-05-19       Impact factor: 5.469

3.  Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells.

Authors:  R M Vabulas; P Ahmad-Nejad; C da Costa; T Miethke; C J Kirschning; H Häcker; H Wagner
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

4.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

5.  Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB.

Authors:  M Antonietta Medici; M Teresa Sciortino; Donata Perri; Carla Amici; Elisa Avitabile; Marco Ciotti; Emanuela Balestrieri; Enrico De Smaele; Guido Franzoso; Antonio Mastino
Journal:  J Biol Chem       Date:  2003-07-04       Impact factor: 5.157

Review 6.  NF-kappaB and virus infection: who controls whom.

Authors:  M Gabriella Santoro; Antonio Rossi; Carla Amici
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

7.  Herpes simplex virus glycoprotein K, but not its syncytial allele, inhibits cell-cell fusion mediated by the four fusogenic glycoproteins, gD, gB, gH, and gL.

Authors:  Elisa Avitabile; Giulia Lombardi; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins.

Authors:  Pascal Lopez; Robert J Jacob; Bernard Roizman
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Activation of NF-kappaB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis.

Authors:  Brunella Taddeo; Ting Rong Luo; Weiran Zhang; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

10.  Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells.

Authors:  Jennifer Lund; Ayuko Sato; Shizuo Akira; Ruslan Medzhitov; Akiko Iwasaki
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  77 in total

1.  αvβ3 Integrin Boosts the Innate Immune Response Elicited in Epithelial Cells through Plasma Membrane and Endosomal Toll-Like Receptors.

Authors:  Costanza Casiraghi; Tatiana Gianni; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

2.  MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.

Authors:  Michael L Davies; Janet J Sei; Nicholas A Siciliano; Ren-Huan Xu; Felicia Roscoe; Luis J Sigal; Laurence C Eisenlohr; Christopher C Norbury
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

Review 3.  The Type I Interferon Response and Age-Dependent Susceptibility to Herpes Simplex Virus Infection.

Authors:  Daniel Giraldo; Douglas R Wilcox; Richard Longnecker
Journal:  DNA Cell Biol       Date:  2017-03-09       Impact factor: 3.311

Review 4.  Oncolytic herpes simplex virus interactions with the host immune system.

Authors:  Dipongkor Saha; Hiroaki Wakimoto; Samuel D Rabkin
Journal:  Curr Opin Virol       Date:  2016-08-03       Impact factor: 7.090

5.  Novel drugs targeting Toll-like receptors for antiviral therapy.

Authors:  Mira C Patel; Kari Ann Shirey; Lioubov M Pletneva; Marina S Boukhvalova; Alfredo Garzino-Demo; Stefanie N Vogel; Jorge Cg Blanco
Journal:  Future Virol       Date:  2014-09       Impact factor: 1.831

Review 6.  Recent advances on viral manipulation of NF-κB signaling pathway.

Authors:  Jun Zhao; Shanping He; Arlet Minassian; Junhua Li; Pinghui Feng
Journal:  Curr Opin Virol       Date:  2015-09-15       Impact factor: 7.090

7.  Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH/gL complex and neutralizes VZV infection.

Authors:  Marius Birlea; Gregory P Owens; Emily M Eshleman; Alanna Ritchie; Igor Traktinskiy; Nathan Bos; Scott Seitz; Yevgeniy Azarkh; Ravi Mahalingam; Don Gilden; Randall J Cohrs
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

8.  Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.

Authors:  Monica M Sauter; Joshua J L Gauger; Curtis R Brandt
Journal:  Antiviral Res       Date:  2014-07-01       Impact factor: 5.970

9.  αvβ3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1.

Authors:  Tatiana Gianni; Valerio Leoni; Liudmila S Chesnokova; Lindsey M Hutt-Fletcher; Gabriella Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

10.  Herpes simplex virus US3 tegument protein inhibits Toll-like receptor 2 signaling at or before TRAF6 ubiquitination.

Authors:  Jayita Sen; Xueqiao Liu; Richard Roller; David M Knipe
Journal:  Virology       Date:  2013-03-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.